 "Suven Life Sciences Q4 net falls 47% to Rs 17 cr")
Suven Life Sciences Limited, a Hyderabad-based bio pharmaceutical company, has reported a 47.7% decline in net profit at Rs 16.95 crore for the quarter ended March 2015 due to fall in revenues and profitability. The net profit for the same quarter last year was Rs 32.41 crore.
Total income for the quarter under review decreased 13.28% to Rs 114.47 crore from Rs 132 crore in the corresponding previous quarter.
Net profit for the full year ending March 2014 stood at Rs 108.8 crore, a decrease of 25% over Rs 144.2 crore last year. However revenues were up 3% at Rs 529.4 crore as compared with Rs 513.3 crore in the last fiscal.
"Suven's major thrust on innovative R&D in drug discovery continues with a spending of Rs 56 crore (10.57% of revenue) for the year ended March, 2015," the company said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app